companies that make glp 1 drugs 2025’s Breakthrough GLP-1 Obesity Treatments: Top & Innovations How to Invest in GLP-1

Pharmaceutical companies have been trying to produce small-molecule GLP-1 agonists that are shelf-stable and can be taken orallyfor instance, Pfizer and Eli Lilly have developed Danuglipron and Orforglipron, respectivelybut we know very little about how they work, said Ali Gler, a neuroscientist at the University of Virginia

and other large, high-income countries

In 2022, around 44% of women were overweight, and 18% were obese [1]

Gaziano, 2010)

This article explains the gastrointestinal effects of GLP-1 therapy and provides practical guidance for managing bowel changes during treatment

A summary of all the CV events occurring during these trials are presented in Additional file 1: Table S1